Sirnaomics
€0.68
0
-€0.01-2.17% Today
Statistics
Day High
0.68
Day Low
0.68
52W High
2.2
52W Low
0.32
Volume
-
Avg. Volume
-
Mkt Cap
70.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
27MarExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-2,850.55%Profit Margin
Unprofitable3.44MRevenue
-97.93MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow V5Z.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, focuses on the discovery and development of product candidates for indications with medical needs in the United Sates and the People's Republic of China. Its lead product candidates include STP705 for the treatment cutaneous squamous cell carcinoma in situ; basal cell carcinoma; cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; keloid scarless healing, hypertrophic scarring, and fat sculpting. The company's lead product candidates also comprise STP707 to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; metastatic cutaneous squamous cell carcinoma; non-small cell lung cancer; liver fibrosis; and lung fibrosis. It also develops STP355 for the treatment of pan cancer; STP369 to treat head and neck/bladder cancer; STP779 for the treatment of liver/lung/pancreatic cancer; STP902 to treat breast cancer; STP702 for the treatment of influenza; STP908 to treat COVID-19; RIM730 COVID-19 vaccine; STP909 for the treatment of HPV/cervical cancer; and STP122G for thrombotic disorders. In addition, the company is developing STP125G to treat hypertriglyceridemia; STP144G for the treatment of complement-mediated diseases; STP133G for cardiometabolic; and STP155G for the treatment hepatitis B virus. Sirnaomics Ltd. was founded in 2007 and is headquartered in Gaithersburg, Maryland.
Show more...
CEO
Dr. Hung Fai Poon Ph.D.
Employees
52
Country
Germany
ISIN
KYG2050P1028
WKN
000A3DFAH
Listings
0 Comments
Share your thoughts
FAQ
What is Sirnaomics stock price today?▼
The current price of V5Z.F is €0.68 EUR — it has decreased by -2.17% in the past 24 hours. Watch Sirnaomics stock price performance more closely on the chart.
What is Sirnaomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sirnaomics stocks are traded under the ticker V5Z.F.
Is Sirnaomics stock price growing?▼
V5Z.F stock has fallen by -11.18% compared to the previous week, the month change is a +8% rise, over the last year Sirnaomics has showed a +109.63% increase.
What is Sirnaomics market cap?▼
Today Sirnaomics has the market capitalization of 70.99M
When is the next Sirnaomics earnings date?▼
Sirnaomics is going to release the next earnings report on August 27, 2026.
What is Sirnaomics revenue for the last year?▼
Sirnaomics revenue for the last year amounts to 3.44M EUR.
What is Sirnaomics net income for the last year?▼
V5Z.F net income for the last year is -97.93M EUR.
How many employees does Sirnaomics have?▼
As of April 29, 2026, the company has 52 employees.
In which sector is Sirnaomics located?▼
Sirnaomics operates in the Other sector.
When did Sirnaomics complete a stock split?▼
Sirnaomics has not had any recent stock splits.
Where is Sirnaomics headquartered?▼
Sirnaomics is headquartered in Wan Chai, Germany.